WE-REACH

Request for WE-REACH Proposals

Funding Opportunity: WE-REACH provides resources and project funding up to $200,000 in direct costs to accelerate impactful product development based on innovations in the life sciences. WE-REACH awards are available for the commercial development of promising life sciences technologies having a sound scientific basis and high potential for impact on health.

We are now accepting proposals from qualified investigators to declare their interest through our partner CoMotion’s database (CAS) as a first step. You must do so by February 7, 2020 at 5:00pm PST to be considered for the July, 2020 funding round.

Supported WE-REACH projects will have access to an array of experts for product development, regulatory strategy, intellectual property, market analysis, and follow-on grant development in addition to the direct funding stated above. Each selected WE-REACH project will receive independent verification of product concept, reimbursement strategy, and IP development from the National REACH Technology Guidance Committee (RTGC) (composed of members from the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Center for Medicare and Medicaid Services (CMS), Kaiser Permanente, and the United States Patent and Trade Office (USPTO). These are value-added services in addition to the cash award.

WE-REACH submissions are supported by our partner CoMotion’s portal: CoMotion CAS Portal

For the full description of the RFP including submission instructions and appendices, follow the link: WE-REACH RFP